Literature DB >> 8332501

Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions.

M A Walls1, K C Hsiao, L J Harris.   

Abstract

Cassette vectors have been constructed for mammalian expression of complete immunoglobulin heavy and light chain genes whose variable regions are produced by the polymerase chain reaction (PCR). The light and heavy chain vectors have promoter, leader, partial intron, enhancer and constant region segments within modified pSV2-gpt and pSV2-neo plasmids, respectively. Variable (V) regions are obtained by PCR using a two step process: 1) the V gene is amplified from genomic or cDNA, cloned into an intermediate vector and sequenced; 2) the first PCR product serves as the template for a second amplification in which restriction enzyme recognition sites and limited flanking intron sequence are added. The second PCR product is inserted into the expression vector, which is then transfected into mouse myeloma cells. These vectors contain human constant regions and may be used to express chimeric, humanized or human Ig genes. This report describes the design of these vectors and their application for the expression of chimeric 60.3, an anti-CD18 antibody.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8332501      PMCID: PMC309684          DOI: 10.1093/nar/21.12.2921

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  51 in total

1.  A fast and simple procedure for sequencing double stranded DNA with sequenase.

Authors:  K Hsiao
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

2.  Immunoglobulin V regions of a bactericidal anti-Neisseria meningitidis outer membrane protein monoclonal antibody.

Authors:  J W Larrick; M J Coloma; J del Valle; M E Fernandez; K E Fry; J V Gavilondo-Cowley
Journal:  Scand J Immunol       Date:  1990-08       Impact factor: 3.487

3.  Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.

Authors:  C A Kettleborough; J Saldanha; V J Heath; C J Morrison; M M Bendig
Journal:  Protein Eng       Date:  1991-10

4.  Polymerase chain reaction facilitates the cloning, CDR-grafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins.

Authors:  B L Daugherty; J A DeMartino; M F Law; D W Kawka; I I Singer; G E Mark
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 5.  Construction, function and immunogenicity of recombinant monoclonal antibodies.

Authors:  M Brüggemann; G T Williams; H M Caskey; C Teale; C Spicer; M A Surani; M S Neuberger
Journal:  Behring Inst Mitt       Date:  1990-12

6.  A humanized antibody that binds to the interleukin 2 receptor.

Authors:  C Queen; W P Schneider; H E Selick; P W Payne; N F Landolfi; J F Duncan; N M Avdalovic; M Levitt; R P Junghans; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Humanized antibodies for antiviral therapy.

Authors:  M S Co; M Deschamps; R J Whitley; C Queen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Primer design for the cloning of immunoglobulin heavy-chain leader-variable regions from mouse hybridoma cells using the PCR.

Authors:  M J Coloma; J W Larrick; M Ayala; J V Gavilondo-Cowley
Journal:  Biotechniques       Date:  1991-08       Impact factor: 1.993

9.  Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.

Authors:  H V Raff; C Bradley; W Brady; K Donaldson; L Lipsich; G Maloney; W Shuford; M Walls; P Ward; E Wolff
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

10.  Statistical analysis of mammalian pre-mRNA splicing sites.

Authors:  M S Gelfand
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

View more
  1 in total

1.  Production and characterization of chimeric monoclonal antibodies against Burkholderia pseudomallei and B. mallei using the DHFR expression system.

Authors:  Hyung-Yong Kim; Shien Tsai; Shyh-Ching Lo; Douglas J Wear; Mina J Izadjoo
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.